Search results
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene...
Editas Medicine is a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world.
We are researching and developing two types of gene editing medicines: in vivo gene editing medicines that edit genes inside the body, and ex vivo gene editing medicines where the gene editing occurs outside the body to create edited cell medicines that are administered to patients.
Oct 16, 2023 · Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases.
Nov 17, 2022 · As a clinical stage genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world.
2 days ago · Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR...
